Hormonal
In nonalcoholic fatty liver disease (NAFLD), the presence of hepatic cholesterol crystals within hepatocyte lipid droplets and the subsequent formation of Kupffer cell 'crown-like structures' around dead hepatocytes distinguish nonalcoholic steatohepatitis (NASH) from simple steatosis.
If you have fatty liver, simply reducing fat intake might not be enough if cholesterol crystallization is driving inflammation. The presence of cholesterol crystals and the resulting immune response (crown-like structures) are key markers of serious liver disease (NASH) versus simple fat accumulation. Managing this likely requires addressing the underlying metabolic drivers of cholesterol handling and inflammation, not just total fat intake.
Our results suggest that cholesterol crystallization within hepatocyte lipid droplets and aggregation and activation of Kupffer cells in crown-like structures around such droplets represent an important, novel mechanism for progression of simple steatosis to NASH.
Why this rating
The study uses a small human sample (n=7) and a small mouse model (n=16), limiting statistical power and generalizability, despite clear histological findings.
Source
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
George N. Ioannou et al. · Journal of Lipid Research · 2013
DOI 10.1194/jlr.m034876
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →